The Skin–Liver Axis Modulates the Psoriasiform Phenotype and Involves Leucine-Rich α-2 Glycoprotein

نویسندگان

چکیده

Abstract Leucine-rich α-2 glycoprotein (LRG), one of the acute phase proteins mainly produced by liver, similar to C-reactive protein, has been recognized as an inflammatory biomarker for rheumatoid arthritis and bowel diseases. We recently demonstrated that LRG was also increased in sera psoriasis patients correlated well with disease activity a sensitivity specificity much higher than protein; however, whether mechanistically contributed pathogenesis remained unclear. In this study, we explored role psoriasiform inflammation using LRG-knockout (KO) mice imiquimod (IMQ)–mediated model. Following topical treatment IMQ, serum levels its expression liver were abruptly elevated. Similarly, surge proinflammatory cytokines observed including IL-1β, TNF-α, IL-6, although LRG-KO showed delayed responses. less skin IMQ model wild-type mice. K5.Stat3C developed psoriasis-like lesions following tape stripping, which induced liver. A deficiency Lrg mitigated stripping–induced lesions, These results indicate modulates both feed-forward feedback loops skin–liver axis involved inflammation.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis

Leucine-rich α2 glycoprotein (LRG1), a serum protein produced by hepatocytes, has been implicated in angiogenesis and tumor promotion. Our laboratory previously reported the expression of LRG1 in murine myeloid cell lines undergoing neutrophilic granulocyte differentiation. However, the presence of LRG1 in primary human neutrophils and a role for LRG1 in regulation of hematopoiesis have not bee...

متن کامل

Leucine‐rich α‐2 glycoprotein promotes lung fibrosis by modulating TGF‐β signaling in fibroblasts

TGF-β has an important role in fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Detailed analysis of TGF-β signaling in pulmonary fibrosis at the molecular level is needed to identify novel therapeutic targets. Recently, leucine-rich alpha-2 glycoprotein (LRG) was reported to function as a modulator of TGF-β signaling in angiogenesis and tumor progression. However, the involvem...

متن کامل

Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.

Purpose Retinoblastomas' growth rate is dependent on their ability to induce neovascularization. Leucine-rich α-2-glycoprotein-1 (LRG-1) was recently reported to be upregulated in human retinal disease with neovascular pathology. The purpose of the study was to determine LRG-1 expression in human retinoblastoma and to correlate it with clinical and histopathologic parameters and to assess how i...

متن کامل

Leucine-rich α-2-glycoprotein promotes TGFβ1-mediated growth suppression in the Lewis lung carcinoma cell lines

Leucine-rich α2-glycoprotein (LRG) is an approximately 50-kDa glycoprotein that has been found to be elevated in the sera of patients with several types of cancer. LRG directly binds to transforming growth factor beta 1 (TGFβ1) and modulates TGFβ1 signaling in endothelial cells; however, the precise function of LRG in cancer remains unclear. This study aimed to investigate the role of LRG in ca...

متن کامل

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients

BACKGROUND New biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrence. We previously demonstrated the upregulation of leucine-rich alpha-2-glycoprotein-1 (LRG1) in the sera of ovarian cancer patients compared to healthy wome...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Immunology

سال: 2021

ISSN: ['1550-6606', '0022-1767']

DOI: https://doi.org/10.4049/jimmunol.2000502